Optimi Health Corp. is a homegrown, Canadian success story producing and supplying natural, EU-GMP grade psilocybin, functional mushrooms, and synthetic psychedelics that focus on the health and wellness markets.
People don’t want to just be better — they want to be exceptional. They want to live life at the next level — mentally, emotionally, psychologically, and physically.
Founders Dane Stevens, JJ Wilson, and Bryan & Jacob Safarik started Optimi with a belief that psychedelic medicine and functional mushrooms might improve health and further unlock human potential.
As explorers, innovators, and industry leaders, the Optimi team is continually growing and researching novel, powerful formulations derived from psilocybin — the naturally-occurring psychedelic substance found in certain mushrooms — as well as other synthetic psychedelic compounds.
Our promise is to make possible a future whereby natural and synthetic psychedelic alternatives aid a wide variety of mental health conditions.
Our goal is to be the number one trusted, compassionate supplier of safe, natural EU-GMP-grade psilocybin and synthetic psychedelics in the world.
Through our purpose-built, pharmaceutical-grade EU-GMP cultivation and analytical facilities, Optimi sits at the forefront of a psychedelic revolution poised to profoundly change the way we view ourselves and live our lives.
Welcome to Optimi.
This Is Our Story.
Optimi Health Corp.
330 – 1122 Mainland Street, Vancouver, BC V6B 5L1
Legal Counsel: Norton Rose Fulbright
Auditor: Smythe CPA
Transfer Agent: Endeavor Trust
Corporate Visibility & Investor Relations: Kydder Group
Trading Symbol: CSE: OPTI | OTC:OPTHF |
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
Issued & Outstanding: (30/06/2022) 80,451,883
Incorporated: BC / May 27, 2020
Year End: September 30th
Products do not contain psilocybin